1XRN062326-CM-UVAPurified anti-human CD36 and 8 more items

BioLegend Inc. was awarded a contract by the University of Virginia on June 25, 2026, for the supply of purified monoclonal antibodies and related immunological reagents. The cumulative contract value totals $1,027.65. The contract is designated as A207_PO-0452031 and is being performed in Virginia. Delivery of all line items is directed to Melissa A. Marshall.

The nine line items comprise purified anti-human antibody products targeting various cell surface markers and receptors, including anti-CD36, anti-CD79a, anti-Syk, anti-CD161, anti-CD23, anti-CD268 (BAFF-R), anti-CD267 (TACI), anti-CD294 (CRTH2), and anti-CD186 (CXCR6). Each line item represents a single unit purchase with unit prices ranging from $72.80 to $190.45. These antibodies are commonly utilized in immunological research and flow cytometry applications for identification and analysis of specific immune cell populations and phenotyping studies.